These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37494725)

  • 1. NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy.
    Sun Q; Guo W; Yue T; Wang L; Mou H
    Gac Med Mex; 2023; 159(3):255-261. PubMed ID: 37494725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
    PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
    Li X; Li Z; Li B; Zhu X; Lai X
    Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
    Zhang L; Ai C; Bai M; Niu J; Zhang Z
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications.
    Ding K; Song C; Hu H; Yin K; Huang H; Tang H
    Oxid Med Cell Longev; 2022; 2022():3790721. PubMed ID: 36111168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy.
    Sun X; Sun X; Meng H; Wu J; Guo X; Du L; Wu H
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation.
    Yan M; Li L; Wang Q; Shao X; Luo Q; Liu S; Li Y; Wang D; Zhang Y; Diao H; Rong X; Guo J
    Biomed Pharmacother; 2022 Apr; 148():112709. PubMed ID: 35190353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
    Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
    Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K/AKT pathway.
    Wang F; Wang J; Liang X; Wu Z; Xue J; Yin L; Wei L; Zhang X
    J Drug Target; 2024 Dec; 32(2):148-158. PubMed ID: 38088811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation.
    Li X; Ke X; Li Z; Li B
    Biochem Biophys Res Commun; 2019 Jun; 514(1):1-8. PubMed ID: 31014675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
    Xu D; Zhang X; Chen X; Yang S; Chen H
    Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
    Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
    J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts.
    Weng L; Li L; Zhao K; Xu T; Mao Y; Shu H; Chen X; Chen J; Wu J; Guo X; Tu J; Zhang D; Sun W; Kong X
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):413-424. PubMed ID: 35156147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
    Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention.
    Sun Y; Ding S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
    Rai RC; Bagul PK; Banerjee SK
    Life Sci; 2020 Jul; 253():117727. PubMed ID: 32371063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pyroptosis in diabetic cardiomyopathy: an updated review.
    Wang G; Ma TY; Huang K; Zhong JH; Lu SJ; Li JJ
    Front Endocrinol (Lausanne); 2023; 14():1322907. PubMed ID: 38250736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.